Co-Diagnostics Inc. (CODX)
NASDAQ · Healthcare
Co-Diagnostics Inc. Shareholder Equity 2017–2025
Co-Diagnostics Inc. annual shareholder equity history from 2017 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Co-Diagnostics Inc. shareholder equity as of December 31, 2025: 20.6M, a 61.71% decrease year-over-year.
- Co-Diagnostics Inc. shareholder equity for 2025 were 20.6M, a 61.71% decrease from 2024.
- Co-Diagnostics Inc. shareholder equity for 2024 were 53.9M, a 37.04% decrease from 2023.
- Co-Diagnostics Inc. shareholder equity for 2023 were 85.6M, a 25.27% decrease from 2022.
- Co-Diagnostics Inc. shareholder equity for 2022 were 114.5M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Co-Diagnostics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $21 |
| 2024 | $54 |
| 2023 | $86 |
| 2022 | $115 |
| 2021 | $134 |
| 2020 | $67 |
| 2019 | $2 |
| 2018 | $-1 |
| 2017 | $4 |
Co-Diagnostics Inc. Shareholder Equity — FAQ
Co-Diagnostics Inc. (CODX) shareholder equity over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CODX's shareholder equity history?
The chart and table above show Co-Diagnostics Inc.'s shareholder equity by year and by quarter, including the growth rate.